ArticleBMC cancer2025

Luteolin as an adjuvant effectively enhanced the efficacy of adoptive tumor-specific CTLs therapy.

Zhiheng Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.